Brace Pharma is a Maryland- based investment company specialized in investments in clinical-stage projects.
Brace Pharma Capital is a strategic investment company formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors. We invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 13, 2019
Avidity Biosciences
|
Series C | $100M | Biotechnology | — |
Oct 17, 2018
Avidity Biosciences
|
Series B | $16M | Biotechnology | — |
Jan 8, 2016
Zymeworks
|
Series A | $61.50M | Biotechnology | — |